We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDQ
126
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$2.76M 0.06%
+113,392
New +$2.78M
IJH icon
127
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.75M 0.06%
52,505
-685
-1% -$34K
MDT icon
128
Medtronic
MDT
$105B
$2.72M 0.06%
30,926
-3,742
-11% -$322K
SPSB icon
129
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$2.71M 0.06%
92,118
BILS icon
130
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.84B
$2.7M 0.06%
+27,131
New +$2.69M
OEF icon
131
iShares S&P 100 ETF
OEF
$19.8B
$2.64M 0.06%
12,752
XYL icon
132
Xylem
XYL
$27.8B
$2.63M 0.06%
23,351
-57
-0.2% -$6.03K
UL icon
133
Unilever
UL
$130B
$2.61M 0.06%
44,573
-489
-1% -$29K
SPIB icon
134
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$2.55M 0.06%
79,554
COP icon
135
ConocoPhillips
COP
$146B
$2.54M 0.06%
24,560
+132
+0.5% +$13.6K
AGZ icon
136
iShares Agency Bond ETF
AGZ
$553M
$2.47M 0.06%
23,046
MCK icon
137
McKesson
MCK
$96.5B
$2.35M 0.05%
5,502
+4,062
+282% +$1.56M
GE icon
138
GE Aerospace
GE
$362B
$2.33M 0.05%
26,572
-1,798
-6% -$146K
ZTS icon
139
Zoetis
ZTS
$31.3B
$2.32M 0.05%
13,462
-665
-5% -$115K
WFC icon
140
Wells Fargo
WFC
$261B
$2.11M 0.05%
49,424
-300
-0.6% -$12.1K
SPHQ icon
141
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$2.08M 0.05%
41,254
-792
-2% -$38.2K
TFX icon
142
Teleflex
TFX
$5.81B
$2.06M 0.05%
8,528
-375
-4% -$93.9K
MO icon
143
Altria Group
MO
$120B
$2.02M 0.05%
44,675
+354
+0.8% +$16K
PPG icon
144
PPG Industries
PPG
$25.4B
$2.01M 0.05%
13,562
-202
-1% -$28.2K
EMN icon
145
Eastman Chemical
EMN
$7.77B
$1.96M 0.04%
23,456
GIS icon
146
General Mills
GIS
$19B
$1.95M 0.04%
25,388
-200
-0.8% -$17.1K
CMCSA icon
147
Comcast
CMCSA
$78.3B
$1.94M 0.04%
46,754
-3,425
-7% -$136K
LOW icon
148
Lowe's Companies
LOW
$113B
$1.85M 0.04%
8,211
+621
+8% +$129K
NXPI icon
149
NXP Semiconductors
NXPI
$70B
$1.82M 0.04%
8,903
-3,980
-31% -$707K
STT icon
150
State Street
STT
$50.6B
$1.82M 0.04%
24,852
-1,278
-5% -$91.9K

Similar funds

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.